Non-clinical radiation biology and pharmacology models: appraisal of state-of-the-art and innovation
Authors:
- 9 August 2019
- journal article
- editorial
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 96 (1) , 1-3
Abstract
Non-clinical Radiation Biology and Pharmacology Models: Appraisal of State-of-the-Art and Innovation. International Journal of Radiation Biology. Accepted .Keywords
This publication has 18 references indexed in Scilit:
- The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpoxAntiviral Research, 2019
- Lifelong Residual bone Marrow Damage in Murine Survivors of the Hematopoietic Acute Radiation Syndrome (H-ARS): A Compilation of Studies Comprising the Indiana University ExperienceHealth Physics, 2019
- CONCEPTS OF OPERATIONS FOR A US DOSIMETRY AND BIODOSIMETRY NETWORKRadiation Protection Dosimetry, 2019
- Development of a biodosimeter for radiation triage using novel blood protein biomarker panels in humans and non-human primatesInternational Journal of Radiation Biology, 2019
- NZO/HlLtJ as a novel model for the studies on the role of metabolic syndrome in acute radiation toxicityInternational Journal of Radiation Biology, 2019
- Impact analysis of age on radiation casualty estimations for nuclear detonation scenariosInternational Journal of Radiation Biology, 2018
- Modeling radiation-induced lung injury: lessons learned from whole thorax irradiationInternational Journal of Radiation Biology, 2018
- Characterization of a partial-body irradiation model with oral cavity shielding in nonhuman primatesInternational Journal of Radiation Biology, 2018
- Radiation Injury After a Nuclear Detonation: Medical Consequences and the Need for Scarce Resources AllocationDisaster Medicine and Public Health Preparedness, 2011
- Radiation Event Medical Management (REMM): Website Guidance for Health Care ProvidersPrehospital Emergency Care, 2008